Agreement signed to expand access to UAE-manufactured specialty medicines
Abu Dhabi, UAE – 22 October 2026 – Arabian Ethicals, a top 10 UAE pharmaceutical distributor, and Mubadala Bio, a life sciences company dedicated to pursuing better health outcomes for the UAE and beyond, have announced a strategic partnership to expand access to UAE-manufactured specialty medicines.
The partnership was formalized during a signing ceremony at the Abu Dhabi Future Health Summit.
Under the agreement, Arabian Ethicals will distribute and promote a portfolio of specialty medicines manufactured by Mubadala Bio in the UAE, spanning oncology and hematology, critical-care anti-infectives, nephrology, and neurology.
The partnership brings together Mubadala Bio’s local manufacturing capabilities and Arabian Ethicals’ established distribution network and commercial expertise. The collaboration aims to improve supply security, support the UAE’s vision for a resilient, self-sufficient healthcare sector, and ensure healthcare professionals and patients have reliable access to high-quality treatments.
Leadership Perspectives
Ebru Yavuz, General Manager of Arabian Ethicals, said:
“Our partnership with Mubadala Bio marks an important milestone for Arabian Ethicals and for healthcare in the UAE. By combining Mubadala Bio’s local manufacturing capabilities with our distribution strength and commercial expertise, we are bringing high-quality specialty medicines, made in the UAE, closer to the hospitals, healthcare professionals, and patients who depend on them. This collaboration supports the nation’s vision for a resilient, self-sufficient healthcare sector, and we are proud to play our part in it.”
Faisal Foulad, General Manager, UAE Pharma Manufacturing Platform at Mubadala Bio, said:
“This partnership reflects our commitment to strengthening the UAE’s drug security and expanding access to high-quality specialty medicines manufactured in the UAE. By combining our manufacturing expertise with Arabian Ethicals’ established commercial and distribution capabilities, we can help ensure that critical treatments reach the healthcare professionals and patients who need them. Together, we are supporting the development of a more resilient and self-sufficient life sciences sector in the UAE.”
About Arabian Ethicals
Established in 1977, Arabian Ethicals, a Ghobash Group enterprise, is a leading UAE-based healthcare distributor with a strong focus on pharmaceuticals, consumer health, and animal care.
The company enables global partners to navigate the UAE market through regulatory expertise, strong public-private relationships, and deep regional insight. With a portfolio spanning high-impact therapeutic areas such as oncology and diabetes, Arabian Ethicals is committed to improving patient access and advancing healthcare outcomes across the region.
Website: arabianethicals.ae
Email: info@arabianethicals.ae
LinkedIn: Arabian Ethicals
Media Contact
Tony Hamad
Group Marketing Director
Phone: +971 4 596 1800
